New long-term data from diabetic retinopathy and wet AMD programs to be presented at American Society of Retina Specialists (ASRS) 2026 ROCKVILLE, Md., June 29 ...
TrilliumBiO, a leader in biomarker discovery and precision diagnostics, today announced a commitment to raising awareness of ...
NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing ...
These 8 healthcare stocks delivered strong gains last week. Discover what drove each rally—and why not all rallies are ...
The company is planning to test its oral immunotherapy in over 800 patients with resectable and unresectable tumors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results